Expression and function of TRAF-3 splice-variant isoforms in human lymphoma cell lines

Area of Science:

• Immunology
• Molecular Biology
• Cell Signaling

Background:

• Tumor necrosis factor receptor-associated factor 3 (TRAF-3) is crucial for lymphocyte-mediated antibody responses.
• Previous studies identified eight splice-variant TRAF-3 mRNAs, with seven activating NF-kappaB in 293 cells.

Purpose of the Study:

• To characterize the expression of TRAF-3 splice variants in T and B cell lines.
• To investigate the functional impact of TRAF-3 splice variants on NF-kappaB activation in B cells.

Main Methods:

• RNAse protection assay was used to determine the expression levels of TRAF-3 splice variants in Jurkat D1.1 (T cell) and BJAB, Daudi, Raji (B cell) lines.
• Over-expression studies in BJAB cells were performed to assess the NF-kappaB activating potential of different TRAF-3 splice variants.

Main Results:

• TRAF-3 splice variants were expressed in T and B cell lines in a similar rank order, with TRAF-3 Delta103aa, Delta83aa, and full-length being the most abundant.
• TRAF-3 Delta130aa mRNA was undetectable in all examined cell lines.
• Only TRAF-3 Delta27aa, Delta103aa, and Delta130aa variants induced NF-kappaB activation in BJAB cells, differing from their activity in 293 cells.

Conclusions:

• Multiple TRAF-3 splice-variant mRNAs are expressed in B and T lymphoma cell lines.
• Specific TRAF-3 splice variants exhibit differential NF-kappaB activating functions depending on the cellular context.
• These findings suggest that certain TRAF-3 splice variants may play a role in mediating the known functions of TRAF-3 in lymphocytes.